@fidjissimo: I think @drmichaellevin is doing some of the most interesting science out there. In the future medicine will expand fro…
Summary
The post discusses the potential of bioelectricity in future medicine, highlighting Dr. Michael Levin's research on reprogramming cells through electrical signals and suggesting that next-generation pharmaceutical companies will focus on this field.
View Cached Full Text
Cached at: 09/23/26, 04:04 AM
I think @drmichaellevin is doing some of the most interesting science out there. In the future medicine will expand from chemistry towards bioelectricity, basically learning to reprogram cells through electrical signals. The science is a bit early still but I think the next big pharma companies will be in that field.
Arjun Khemani (@arjunkhemani): My conversation with @drmichaellevin, a biologist at Tufts University whose research explores bioelectricity, regeneration, morphogenesis, and how cells collectively process information to build and repair bodies.
Timestamps: 0:00 - Causes and downstream effects of aging 3:31 -
Similar Articles
@tferriss: “If some bullshit hype filters into this, it’s worth it in order to take the correct swings at the truly big ideas, bec…
This article announces Tim Ferriss's podcast episode featuring Jacob Becraft, CEO of Strand Therapeutics, discussing the revolution in genetic medicine and programmable RNA therapies.
@fidjissimo: While AI gives me a lot of hope to find cures for complex chronic conditions like mine, this potential will only be rea…
Former OpenAI executive Fidji Simo discusses her new startup ChronicleBio, which aims to use AI and a biobank of 3,500 blood samples to find cures for chronic conditions like POTS.
The Future Of Brain-Computer Interfaces
The article discusses the current state and future of brain-computer interfaces (BCIs), highlighting Science's Prima retinal implant that has restored partial vision in over 40 patients. It explores neural plasticity, the trade-off between surgical risks and benefits, and the potential for BCIs to eventually enhance healthy individuals.
Meet the under-35s shaping the future of biotech
MIT Technology Review features five young innovators under 35 working on groundbreaking biotech projects, including a postpartum hemorrhage device, advanced brain electrodes, personalized gene-editing therapy, age-reversal eye treatment, and AI-designed viruses.
@itsolelehmann: Demis Hassabis says he can cure every disease in 10 years. Most people roll their eyes when they hear this, but I don't…
Demis Hassabis claims AI can cure all diseases within 10 years, backed by a $2.1B funding round for Isomorphic Labs to accelerate AI-driven drug discovery and personalized medicine.